We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STGW icon
2926
Stagwell
STGW
$2.22B
$374K ﹤0.01%
134,341
-19,897
-13% -$53.6K
APLT
2927
DELISTED
Applied Therapeutics
APLT
$373K ﹤0.01%
+13,641
New +$234K
DHX icon
2928
DHI Group
DHX
$158M
$372K ﹤0.01%
123,384
PMBC
2929
DELISTED
Pacific Mercantile Bancorp
PMBC
$365K ﹤0.01%
44,903
CHMG icon
2930
Chemung Financial Corp
CHMG
$392M
$363K ﹤0.01%
8,519
PLSE icon
2931
Pulse Biosciences
PLSE
$2.96B
$362K ﹤0.01%
26,993
CELH icon
2932
Celsius Holdings
CELH
$6.89B
$359K ﹤0.01%
222,624
+16,269
+8% +$21.6K
CSTL icon
2933
Castle Biosciences
CSTL
$988M
$356K ﹤0.01%
+10,335
New +$253K
SNDA icon
2934
Sonida Senior Living
SNDA
$1.99B
$353K ﹤0.01%
7,598
-1,276
-14% -$74.6K
LEVL
2935
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$353K ﹤0.01%
14,025
+3,011
+27% +$73.9K
SVRA icon
2936
Savara
SVRA
$1.17B
$350K ﹤0.01%
78,019
FLXS icon
2937
Flexsteel Industries
FLXS
$307M
$349K ﹤0.01%
17,505
+359
+2% +$6.26K
RMTI icon
2938
Rockwell Medical
RMTI
$27M
$349K ﹤0.01%
1,299
CCB icon
2939
Coastal Financial
CCB
$743M
$348K ﹤0.01%
21,089
+4,438
+27% +$71.7K
UBFO
2940
DELISTED
United Security Bancshares
UBFO
$347K ﹤0.01%
32,297
ZYNE
2941
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$347K ﹤0.01%
57,333
HWBK icon
2942
Hawthorn Bancshares
HWBK
$275M
$343K ﹤0.01%
15,709
IWR icon
2943
iShares Russell Mid-Cap ETF
IWR
$57.5B
$343K ﹤0.01%
+5,750
New +$330K
SGC icon
2944
Superior Group of Companies
SGC
$206M
$343K ﹤0.01%
25,305
SCWX
2945
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$343K ﹤0.01%
20,546
UNB icon
2946
Union Bankshares
UNB
$117M
$341K ﹤0.01%
9,399
SRT
2947
DELISTED
Startek Inc.
SRT
$338K ﹤0.01%
42,344
+2,742
+7% +$20K
KNSA icon
2948
Kiniksa Pharmaceuticals
KNSA
$5.97B
$337K ﹤0.01%
30,440
-5,964
-16% -$51.8K
XFOR icon
2949
X4 Pharmaceuticals
XFOR
$421M
$337K ﹤0.01%
1,048
FNCB
2950
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$336K ﹤0.01%
39,720

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.